s6y

Bambusa Therapeutics, Inc.

Ticker
BBTX
CIK
2044950
Industry
Biological Products, (No Diagnostic Substances)

News 1

  1. 8-K Current report filing

Ownership 14

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 14 ownership filings

Prospectus 7

  1. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. S-1MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
  4. S-1/A General form of registration statement for all companies including face-amount certificate companies
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  7. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Other 8

  1. SCHEDULE 13D
  2. SCHEDULE 13G
  3. EFFECT Notice of Effectiveness
  4. CERT Certification by an exchange approving securities for listing
  5. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  6. D Exempt (Private) Offering
  7. D Exempt (Private) Offering
  8. D Exempt (Private) Offering